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1Errata
In the table of contents of the November 2006 issue of Biology of Blood and Marrow Transplantation (Volume
12, Number 11), the authorship of the ASBMT Committee Report entitled “Preparing for the Unthinkable:
Emergency Preparedness for the Hematopoietic Cell Transplant Program,” should be John R. Wingard,
Alan K. Leahigh, Dennis Confer, John Edwards, Rocky L. Billups, Marcel van den Brink, and Armand
Keating. The authors are stated correctly on the title page of the article (page 1229).
In the article entitled “Encouraging Results with Inolimomab (Anti-IL-2 Receptor) as Treatment for
Refractory Acute Graft-versus-Host Disease” by Piñana JL et al. in the November 2006 issue of Biology of
Blood and Marrow Transplantation (Volume 12, Number 11, pages 1135-1141), the drug name Enlimomab in
the abstract and body of the article should be Inolimomab, as stated correctly in the title.24
